Published • loading... • Updated
Anvisa Bans Irregular Lots of Medication for Multiple Sclerosis
Summary by Forbes Brasil
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Fibres, teas and other products of natural origin may complement healthy habits, but do not replace adequate food and professional follow-up
Forbes, the world's most well-conceived journal of business and economics. Resolution was published in the Official Journal of the Union The post Anvisa Bans Irregular Lots of Medication for Multiple Sclerosis apareceu primeiro em Forbes Brasil.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
